Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

IIVS News & Views

IIVS News & Views ATLA 45, 173, 2017 173 gramme, participants will gain the informa- IIVS at the 10th World Congress on tion and expertise to integrate non-animal test Alternatives and Animal Use in the methods into their testing programmes. Life Sciences Participants will attend lectures given by IIVS scientists and get hands-on experience in the IIVS officers and staff attended the 10th World laboratory with new and novel assay tech- Congress, held on 20–24 August 2017, in niques. Space is limited. Learn more and reg- Seattle, Washington, USA. IIVS oral presenta- ister at www.iivs.org. tions and posters included: — Collaborative Industry and Regulatory Eff - orts to Implement Alternative Methods in China (Erin Hill) Chinese FDA and IIVS Re-affirm Their — Why Regulatory Acceptance Doesn’t Necess - Collaboration for Non-animal Tests arily Result in Industry Use of Alternatives (Erin Hill) Bo Li, Director General Director of the CFDA’s — The Practical Application of In Vitro National Institute for Food and Drug Control Pulmonary Models to Assess Acute and (NIFDC), and Erin Hill, President of US-based Chronic Effects of Toxic Exposure (Rodger non-profit organisation, Institute for In Vitro Curren) Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring non-animal test — Industry and Regulatory Collaboration to methods to China for the regulation of cosmet- Help Modernize the US EPA 6 Pack: Revised ics and ingredients. The move re-affirms and Prediction Model of the Skin Irritation Test expands a three-year partnership between the (Rodger Curren) NIFDC and IIVS. Read the full press release at — Sharing Technology and Expertise: A US www.iivs.org. Society Promotes the Use of Alternatives Through Its Membership Activities (Erin Hill) — Non-animal Testing Approach to Address Biocompatibility Testing of Medical Devices Collaborative Effort Aims to Replace Required by the United States Food and Drug Rabbit Test for Personal Lubricant Administration (US FDA) Products — Quality Considerations: Redefining Test Systems from Animals to Tissues and Beyond A first-of-its kind collaborative project is under- — Validation and Application of the 3D-Human way to find a non-animal test method to replace Reconstructed Skin Micronucleus Assay the rabbit vaginal irritation test for personal (RSMN) using the EpiDerm™ lubricants. The US Food and Drug Admin - — Tissue to the Safety Assessment of Cosmetics istration (FDA) gave the project a green light as Ingredients part of the agency’s programme aimed at mod- ernising the tests used to develop and evaluate — Introducing the 3R Concepts into Pre-college medical devices. Classrooms The work of the lubricant industry, the View posters at www.iivs.org. Institute for In Vitro Sciences (IIVS), the PETA International Science Consortium Ltd, and the Consumer Healthcare Products Association (CHPA), follows efforts to show Registration Open for 2018 IIVS that animal testing for lubricants can and should be replaced by non-animal methods, in Practical Methods Workshop part because rabbits and humans have very different physiologies. Read the full press Registration is open for the IIVS’ annual training workshop. During the four-day pro- release at www.iivs.org. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

IIVS News & Views

Alternatives to Laboratory Animals , Volume 45 (4): 1 – Sep 1, 2017

Loading next page...
 
/lp/sage/iivs-news-views-UdWv00vgt0

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
SAGE
Copyright
© 2017 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119291704500404
Publisher site
See Article on Publisher Site

Abstract

ATLA 45, 173, 2017 173 gramme, participants will gain the informa- IIVS at the 10th World Congress on tion and expertise to integrate non-animal test Alternatives and Animal Use in the methods into their testing programmes. Life Sciences Participants will attend lectures given by IIVS scientists and get hands-on experience in the IIVS officers and staff attended the 10th World laboratory with new and novel assay tech- Congress, held on 20–24 August 2017, in niques. Space is limited. Learn more and reg- Seattle, Washington, USA. IIVS oral presenta- ister at www.iivs.org. tions and posters included: — Collaborative Industry and Regulatory Eff - orts to Implement Alternative Methods in China (Erin Hill) Chinese FDA and IIVS Re-affirm Their — Why Regulatory Acceptance Doesn’t Necess - Collaboration for Non-animal Tests arily Result in Industry Use of Alternatives (Erin Hill) Bo Li, Director General Director of the CFDA’s — The Practical Application of In Vitro National Institute for Food and Drug Control Pulmonary Models to Assess Acute and (NIFDC), and Erin Hill, President of US-based Chronic Effects of Toxic Exposure (Rodger non-profit organisation, Institute for In Vitro Curren) Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring non-animal test — Industry and Regulatory Collaboration to methods to China for the regulation of cosmet- Help Modernize the US EPA 6 Pack: Revised ics and ingredients. The move re-affirms and Prediction Model of the Skin Irritation Test expands a three-year partnership between the (Rodger Curren) NIFDC and IIVS. Read the full press release at — Sharing Technology and Expertise: A US www.iivs.org. Society Promotes the Use of Alternatives Through Its Membership Activities (Erin Hill) — Non-animal Testing Approach to Address Biocompatibility Testing of Medical Devices Collaborative Effort Aims to Replace Required by the United States Food and Drug Rabbit Test for Personal Lubricant Administration (US FDA) Products — Quality Considerations: Redefining Test Systems from Animals to Tissues and Beyond A first-of-its kind collaborative project is under- — Validation and Application of the 3D-Human way to find a non-animal test method to replace Reconstructed Skin Micronucleus Assay the rabbit vaginal irritation test for personal (RSMN) using the EpiDerm™ lubricants. The US Food and Drug Admin - — Tissue to the Safety Assessment of Cosmetics istration (FDA) gave the project a green light as Ingredients part of the agency’s programme aimed at mod- ernising the tests used to develop and evaluate — Introducing the 3R Concepts into Pre-college medical devices. Classrooms The work of the lubricant industry, the View posters at www.iivs.org. Institute for In Vitro Sciences (IIVS), the PETA International Science Consortium Ltd, and the Consumer Healthcare Products Association (CHPA), follows efforts to show Registration Open for 2018 IIVS that animal testing for lubricants can and should be replaced by non-animal methods, in Practical Methods Workshop part because rabbits and humans have very different physiologies. Read the full press Registration is open for the IIVS’ annual training workshop. During the four-day pro- release at www.iivs.org.

Journal

Alternatives to Laboratory AnimalsSAGE

Published: Sep 1, 2017

There are no references for this article.